文献速递儿科与产科急症重症综合管理与镇静镇痛

延迟与即刻脐带结扎与极低胎龄新生儿严重神经损伤及生存的关系

Association of Deferred vs Immediate Cord Clamping With Severe Neurological Injury and Survival in Extremely Low-Gestational-Age Neonates.
PubMed 文献 · JAMA Netw Open · 2019-03-01
一句话结论回顾性队列显示,极低胎龄新生儿延迟脐带结扎与严重神经损伤或死亡复合结局风险降低相关(AOR 0.80)。

该回顾性队列研究纳入2011年1月1日至2015年12月31日加拿大新生儿网络参与的三级NICU中胎龄22至28周、入院且符合标准的极低胎龄新生儿4680例,其中延迟脐带结扎(DCC)组1852例(39.6%),即刻脐带结扎(ICC)组2828例(60.4%)。DCC组严重神经损伤或死亡复合结局(校正OR 0.80;95%CI 0.67-0.96)、死亡(AOR 0.74;95%CI 0.59-0.93)及严重神经损伤(AOR 0.80;95%CI 0.64-0.99)的 odds 均显著降低。支气管肺发育不良、早产儿视网膜病变3期及以上、坏死性小肠结肠炎2期及以上、晚发型脓毒症及接受2次及以上输血在两组间无显著差异。倾向评分匹配分析显示DCC组死亡(AOR 0.79;95%CI 0.65-0.95)、晚发型脓毒症(AOR 0.81;95%CI 0.69-0.95)及低血压治疗(AOR 0.75;95%CI 0.60-0.95)的 odds 较低。

要点

  • 极低胎龄(22-28周)新生儿中,DCC与严重神经损伤或死亡复合结局 odds 降低相关(AOR 0.80;95%CI 0.67-0.96)。
  • DCC与死亡 odds 降低相关(AOR 0.74;95%CI 0.59-0.93),与严重神经损伤 odds 降低相关(AOR 0.80;95%CI 0.64-0.99)。
  • 倾向评分匹配分析中,DCC组死亡(AOR 0.79;95%CI 0.65-0.95)、晚发型脓毒症(AOR 0.81;95%CI 0.69-0.95)及低血压治疗(AOR 0.75;95%CI 0.60-0.95)的 odds 较低。
  • 支气管肺发育不良、早产儿视网膜病变3期及以上、坏死性小肠结肠炎2期及以上、晚发型脓毒症及接受2次及以上输血在两组间无显著差异。
  • 该研究为回顾性队列,DCC组胎龄中位数27(25-28)周、出生体重中位数930(760-1120)g,ICC组分别为26(25-27)周、870(700-1060)g。

适用人群与场景

  • 胎龄22至28周、入住加拿大新生儿网络参与的三级NICU的极低胎龄新生儿,出生于2011年1月1日至2015年12月31日。
  • 排除:在三级NICU以外出生、出生时濒死、分娩前需姑息治疗、存在重大先天畸形或缺乏脐带结扎信息的新生儿。

研究设计与关键结果

  • 研究类型:回顾性队列研究;纳入4680例极低胎龄新生儿,DCC组1852例(39.6%),ICC组2828例(60.4%)。
  • DCC组男性974例(52.7%),ICC组男性1540例(54.5%);胎龄中位数(四分位距)DCC组27(25-28)周,ICC组26(25-27)周;出生体重中位数(四分位距)DCC组930(760-1120)g,ICC组870(700-1060)g。
  • 主要终点:严重神经损伤(脑室内出血≥3级伴或不伴持续性脑室周围回声增强)或出院前死亡复合结局,DCC组校正OR 0.80(95%CI 0.67-0.96)。
  • 次要终点:死亡AOR 0.74(95%CI 0.59-0.93);严重神经损伤AOR 0.80(95%CI 0.64-0.99);支气管肺发育不良AOR 1.00(95%CI 0.84-1.19);早产儿视网膜病变3期及以上AOR 0.94(95%CI 0.71-1.25);坏死性小肠结肠炎2期及以上AOR 0.86(95%CI 0.66-1.12);晚发型脓毒症AOR 1.02(95%CI 0.85-1.22);接受2次及以上输血AOR 0.93(95%CI 0.79-1.10),均无显著差异。
  • 倾向评分匹配分析:死亡AOR 0.79(95%CI 0.65-0.95);晚发型脓毒症AOR 0.81(95%CI 0.69-0.95);低血压治疗AOR 0.75(95%CI 0.60-0.95),DCC组 odds 较低。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在极低胎龄新生儿中,DCC与严重神经损伤或死亡复合结局风险降低相关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Deferred cord clamping (DCC) is recommended for term and preterm neonates to reduce neonatal complications. Information on the association of DCC with outcomes for extremely low-gestational-age neonates is limited.

OBJECTIVE: To compare neonatal outcomes after DCC and immediate cord clamping (ICC) in extremely low-gestational-age neonates.

DESIGN, SETTING, AND PARTICIPANTS: In this retrospective cohort study, eligible neonates born between January 1, 2011, and December 31, 2015, were divided into 2 groups: DCC and ICC. Neonates were recruited from tertiary neonatal intensive care units participating in the Canadian Neonatal Network, and analysis began in January 2018. Neonates were eligible if they were born at 22 to 28 weeks' gestational age and admitted to a participating Canadian Neonatal Network neonatal intensive care unit during the study period. Neonates who were born outside a tertiary-level neonatal intensive care unit, were moribund at birth, needed palliative care before delivery, had major congenital anomalies, or lacked cord clamping information were excluded.

MAIN OUTCOMES AND MEASURES: Composite of severe neurological injury (intraventricular hemorrhage grade ≥3 with or without persistent periventricular echogenicity) or mortality before discharge.

RESULTS: Of 8221 admitted neonates, 4680 were included in the study, of whom 1852 (39.6%) received DCC and 2828 (60.4%) received ICC. There were 974 (52.7%) male neonates in the DCC group and 1540 (54.5%) male neonates in the ICC group. Median (interquartile range) gestational age was 27 (25-28) weeks for the DCC group and 26 (25-27) weeks for the ICC group. Median (interquartile range) birth weight was 930 (760-1120) g and 870 (700-1060) g for DCC and ICC groups, respectively. Neonates who received DCC had significantly reduced odds of the composite outcome of severe neurological injury or mortality (adjusted odds ratio [AOR], 0.80; 95% CI, 0.67-0.96), mortality (AOR, 0.74; 95% CI, 0.59-0.93), and severe neurological injury (AOR, 0.80; 95% CI, 0.64-0.99). The odds of bronchopulmonary dysplasia (AOR, 1.00; 95% CI, 0.84-1.19), retinopathy of prematurity stage 3 or higher (AOR, 0.94; 95% CI, 0.71-1.25), necrotizing enterocolitis stage 2 or higher (AOR, 0.86; 95% CI, 0.66-1.12), late-onset sepsis (AOR, 1.02; 95% CI, 0.85-1.22), and receipt of 2 or more blood transfusions (AOR, 0.93; 95% CI, 0.79-1.10) did not differ between the groups. Propensity score-matched analyses revealed lower odds of mortality (AOR, 0.79; 95% CI, 0.65-0.95), late-onset sepsis (AOR, 0.81; 95% CI, 0.69-0.95), and treatment for hypotension (AOR, 0.75; 95% CI, 0.60-0.95) in the DCC group.

CONCLUSIONS AND RELEVANCE: In this study of extremely low-gestational-age neonates who received DCC or ICC, DCC was associated with reduced risk for the composite outcome of severe neurological injury or mortality.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Lodha A, Shah PS, Soraisham AS, et al. Association of Deferred vs Immediate Cord Clamping With Severe Neurological Injury and Survival in Extremely Low-Gestational-Age Neonates. JAMA Netw Open. 2019. PMID: 30924898. doi:10.1001/jamanetworkopen.2019.1286

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。